Naproxen use is contraindicated or harmful in patients with Crohn's disease
Evidence indicates that nonsteroidal anti-inflammatory drugs (NSAIDs) such as naproxen can trigger or worsen mucosal damage and inflammation, making them harmful or contraindicated in patients with Crohn's disease.
The retrieved papers include studies and reviews discussing the general adverse gastrointestinal effects of NSAIDs (Paper 3) and specifically highlighting NSAID administration as a major risk factor that triggers and worsens inflammatory bowel disease such as Crohn's disease due to cyclooxygenase inhibition (Paper 7). There are no retrieved papers refuting this claim.
Sam Harirforoosh, Waheed Asghar, Fakhreddin Jamali. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. 2014. https://doi.org/10.18433/j3vw2f
Highlights that adverse effects of NSAIDs, including gastrointestinal complications, make them problematic in conditions like inflammatory bowel disease.
See more details
Kenji Kabashima, Tomomi Saji, Tatsunori Murata, Miyako Nagamachi, Toshiyuki Matsuoka, Eri Segi‐Nishida, Kazuhito Tsuboi, Yukihiko Sugimoto, Takuya Kobayashi, Yoshiki Miyachi, Atsushi Ichikawa, Shuh Narumiya. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. 2002. https://doi.org/10.1172/jci0214459
Explicitly notes that the administration of nonsteroidal anti-inflammatory drugs is a major risk factor triggering and worsening inflammatory bowel disease like Crohn's disease.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt